123 related articles for article (PubMed ID: 19287988)
1. Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo.
Yu M; Gong J; Ma M; Yang H; Lai J; Wu H; Li L; Li L; Tan D
Oncol Rep; 2009 Apr; 21(4):909-15. PubMed ID: 19287988
[TBL] [Abstract][Full Text] [Related]
2. Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer.
Yu M; Ma M; Huang C; Yang H; Lai J; Yan S; Li L; Xiang M; Tan D
Cancer Invest; 2009 Dec; 27(10):978-83. PubMed ID: 19909012
[TBL] [Abstract][Full Text] [Related]
3. [hARD1 antiserum preparation and primary immunohistochemical analysis of hARD1 in tumor tissues].
Yu M; Huang C; Xiang M; Lai J; Yang H; Ma M; Tan D
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1155-61. PubMed ID: 18837388
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
Arnesen T; Anderson D; Baldersheim C; Lanotte M; Varhaug JE; Lillehaug JR
Biochem J; 2005 Mar; 386(Pt 3):433-43. PubMed ID: 15496142
[TBL] [Abstract][Full Text] [Related]
5. [Production of anti-recombinant human arrest defective 1 protein (hARD1) monoclonal antibodies for assaying human breast cancer tissues].
Yu M; Wang Z; Gong J; Ma M; Jiao Y; Huang W; Lü Q; Li L; Yang H; Tan D
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):57-62. PubMed ID: 20353093
[TBL] [Abstract][Full Text] [Related]
6. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.
Lim JH; Park JW; Chun YS
Cancer Res; 2006 Nov; 66(22):10677-82. PubMed ID: 17108104
[TBL] [Abstract][Full Text] [Related]
7. The protein acetyltransferase ARD1: a novel cancer drug target?
Arnesen T; Thompson PR; Varhaug JE; Lillehaug JR
Curr Cancer Drug Targets; 2008 Nov; 8(7):545-53. PubMed ID: 18991565
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
[TBL] [Abstract][Full Text] [Related]
9. Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms.
Arnesen T; Gromyko D; Horvli O; Fluge Ø; Lillehaug J; Varhaug JE
Thyroid; 2005 Oct; 15(10):1131-6. PubMed ID: 16279846
[TBL] [Abstract][Full Text] [Related]
10. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation.
Seo JH; Cha JH; Park JH; Jeong CH; Park ZY; Lee HS; Oh SH; Kang JH; Suh SW; Kim KH; Ha JY; Han SH; Kim SH; Lee JW; Park JA; Jeong JW; Lee KJ; Oh GT; Lee MN; Kwon SW; Lee SK; Chun KH; Lee SJ; Kim KW
Cancer Res; 2010 Jun; 70(11):4422-32. PubMed ID: 20501853
[TBL] [Abstract][Full Text] [Related]
11. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.
Murray-Rust TA; Oldham NJ; Hewitson KS; Schofield CJ
FEBS Lett; 2006 Apr; 580(8):1911-8. PubMed ID: 16500650
[TBL] [Abstract][Full Text] [Related]
12. Nuclear translocation of hARD1 contributes to proper cell cycle progression.
Park JH; Seo JH; Wee HJ; Vo TT; Lee EJ; Choi H; Cha JH; Ahn BJ; Shin MW; Bae SJ; Kim KW
PLoS One; 2014; 9(8):e105185. PubMed ID: 25133627
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.
Arnesen T; Betts MJ; Pendino F; Liberles DA; Anderson D; Caro J; Kong X; Varhaug JE; Lillehaug JR
BMC Biochem; 2006 Apr; 7():13. PubMed ID: 16638120
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex.
Arnesen T; Gromyko D; Pendino F; Ryningen A; Varhaug JE; Lillehaug JR
Oncogene; 2006 Jul; 25(31):4350-60. PubMed ID: 16518407
[TBL] [Abstract][Full Text] [Related]
15. Different subcellular localizations and functions of human ARD1 variants.
Seo JH; Park JH; Lee EJ; Kim KW
Int J Oncol; 2015 Feb; 46(2):701-7. PubMed ID: 25421966
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin.
Lim JH; Chun YS; Park JW
Cancer Res; 2008 Jul; 68(13):5177-84. PubMed ID: 18593917
[TBL] [Abstract][Full Text] [Related]
17. Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.
Shin DH; Chun YS; Lee KH; Shin HW; Park JW
PLoS One; 2009 Oct; 4(10):e7451. PubMed ID: 19826488
[TBL] [Abstract][Full Text] [Related]
18. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer.
Ren T; Jiang B; Jin G; Li J; Dong B; Zhang J; Meng L; Wu J; Shou C
Cancer Lett; 2008 Jun; 264(1):83-92. PubMed ID: 18325661
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of human arrest-defective 1 protein is correlated with metastatic phenotype and poor prognosis in breast cancer.
Wang ZH; Gong JL; Yu M; Yang H; Lai JH; Ma MX; Wu H; Li L; Tan DY
Asian Pac J Cancer Prev; 2011; 12(8):1973-7. PubMed ID: 22292636
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1.
Sánchez-Puig N; Fersht AR
Protein Sci; 2006 Aug; 15(8):1968-76. PubMed ID: 16823041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
